[JAMA] US Food and Drug Administration Approval of Aducanumab¡ªIs Amyloid Load a Valid Surrogate End Point for Alzheimer Disease Clinical Trials?

scut Post time 2024-4-18 10:14:14 | Show all posts |Read mode
Reward10points

journal£ºJAMA Neurology

Authors£ºVincent Planche; Nicolas Villain

Published date£º2021-11-1

DOI£º10.1001/jamaneurol.2021.3126

PDF link£ºhttps://jamanetwork.com/journals ... 636576224.48116.pdf

Article link£ºhttp://dx.doi.org/10.1001/jamaneurol.2021.3126

Article Source£ºAmerican Medical Association (AMA)¡£


Remark£º

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
Rajavarman11 Post time 2024-4-18 10:14:15 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    6242

Latest Reply

Return to the list